Ally Bridge Group’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-735,000
Closed -$3.32M 48
2022
Q2
$3.32M Hold
735,000
3.03% 14
2022
Q1
$5.89M Sell
735,000
-65,000
-8% -$573K 4.37% 10
2021
Q4
$9.31M Hold
800,000
3.25% 15
2021
Q3
$9.91M Buy
+800,000
New +$9.02M 2.91% 14

Other funds holding SLGC

Ally Bridge Group's SLGC Position: Q3 2022 in Review

Ally Bridge Group sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2022, closing a stake of 735,000 shares — an estimated $3.32M sold.

Ally Bridge Group first reported a position in SLGC in Q3 2021 and held it in 4 quarters. The position peaked at $9.91M in Q3 2021. 126 funds tracked by Wall St. Rank hold SLGC as of Q3 2022.

  • Ally Bridge Group reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ally Bridge Group sold 735,000 SomaLogic, Inc. Class A Common Stock shares in Q3 2022, an estimated $3.32M.
  • Ally Bridge Group first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 4 quarters.
  • Ally Bridge Group's SomaLogic, Inc. Class A Common Stock position peaked at $9.91M in Q3 2021.
  • 126 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2022.

Based on Ally Bridge Group's 13F filing for Q3 2022, filed 14 Nov 2022.